Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
31/07/202405:30Edgar (US Regulatory)Form 8-K - Current reportNYSE:PSNParsons Corporation
31/07/202405:30Business WireVeterinary Practice Partners Highlights Commitment to Expanding Practice Ownership in 2024 Mid-Year Update
31/07/202405:30GlobeNewswire Inc.Parsons Reports Record Results Since IPO for the Second Quarter of 2024NYSE:PSNParsons Corporation
31/07/202405:30Business WireHenry Schein Details Progress in 2023 CARES Report on Sustainability and Corporate CitizenshipNASDAQ:HSICHenry Schein Inc
31/07/202405:30Business WireAres Management Closes $34 Billion for U.S. Senior Direct Lending StrategyNYSE:ARESAres Management Co
31/07/202405:30GlobeNewswire Inc.Teleflex Expands Interventional Cardiology Portfolio with FDA 510(k) Clearance of the Ringer™ Perfusion Balloon CatheterNYSE:TFXTeleflex Inc
31/07/202405:30GlobeNewswire Inc.CNH Industrial N.V. Reports Second Quarter 2024 ResultsBIT:CNHICNH Industrial NV
31/07/202405:30GlobeNewswire Inc.MannKind Launches Educational Website to Raise Awareness of NTM Lung DiseaseNASDAQ:MNKDMannKind Corporation
31/07/202405:30Business WireUnited Therapeutics Corporation Reports Second Quarter 2024 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
31/07/202405:30Business WireCentral Pacific Financial Reports Second Quarter 2024 Earnings of $15.8 MillionNYSE:CPFCentral Pacific Financial Corp
31/07/202405:30Business WireHumana Reports Second Quarter 2024 Financial Results; Affirms Full Year Adjusted 2024 Financial GuidanceNYSE:HUMHumana Inc
31/07/202405:30Business WireClean Energy Opens Clean-fuel RNG Station in Davenport, FloridaNASDAQ:CLNEClean Energy Fuels Corp
31/07/202405:30Business WireEasterly Government Properties Reports Second Quarter 2024 ResultsNYSE:DEAEasterly Government Properties Inc
31/07/202405:30GlobeNewswire Inc.Wallbridge Phase 1 Drilling at Martiniere Encounters Multiple High-Grade Vein Structures and Confirms Grade Continuity in Known Mineralized ZonesTSX:WMWallbridge Mining Company Limited
31/07/202405:30Business WireStrategic Education, Inc. Reports Second Quarter 2024 ResultsNASDAQ:STRAStrategic Education Inc
31/07/202405:30Business WireCencora Reports Fiscal 2024 Third Quarter ResultsNYSE:CORCencora Inc
31/07/202405:30Business WireTrane Technologies Reports Strong Second Quarter Results and Raises 2024 Revenue and EPS GuidanceNYSE:TTTrane Technologies plc
31/07/202405:30Business WireMaterialise Reports Second Quarter 2024 ResultsNASDAQ:MTLSMaterialise NV
31/07/202405:30Business WireColumbus McKinnon Reports Continued Sales Growth and Gross Margin Expansion in Q1 FY25; Reaffirms FY25 GuidanceNASDAQ:CMCOColumbus McKinnon Corporation
31/07/202405:29Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:CCitigroup Inc
31/07/202405:29Alliance NewsAlliance NewsZegona says Vodafone Spain and Telefonica create new fibre network JVLSE:TDETelefonica Sa
31/07/202405:28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CSWICSW Industrials Inc
31/07/202405:27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:HSBCHSBC Holdings PLC
31/07/202405:27PR Newswire (US)Delta Dental report: more U.S. adults believe dental insurance is essential to protecting oral and overall health
31/07/202405:25Business WireInviato all'Agenzia Europea per i Medicinali (EMA) il vaccino ricombinante antipertosse di BioNet
31/07/202405:24Alliance NewsAlliance NewsSMALL-CAP WINNERS & LOSERS: Metro Bank ups outlook; IPF buyback
31/07/202405:22Business WireBioNets rekombinanter Keuchhustenimpfstoff bei der Europäischen Arzneimittelagentur (EMA) eingereicht
31/07/202405:21PR Newswire (Canada)Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval
31/07/202405:20Alliance NewsAlliance NewsUK house sales increased by 8% annually in June – HMRC figures
31/07/202405:20Business WireLe vaccin recombinant contre la coqueluche de BioNet soumis à l’Agence européenne des médicaments (EMA)